Deep Track Capital - aVenture Asset Manager Research
Location
Greenwich, CT, US
Founded
2020
Deep Track Capital is a specialized investment firm focusing exclusively on the life sciences and biotechnology sectors. The firm partners with innovative public and pre-IPO biotechnology companies, typically leading transactions and forming large syndicates. Their investments span various stages, including Series A through E rounds and post-IPO equity, with a particular emphasis on Series B funding.
The firm's portfolio includes notable companies such as Aligos Therapeutics, Arbor Biotechnologies, Crinetics Pharmaceuticals, and Metagenomi. Deep Track Capital aims to provide more than just financial support, offering its time, expertise, and network to benefit its partners. This approach underscores their commitment to fostering growth and innovation in the biotechnology industry.
Deep Track Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
